🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOrforglipron Phase 2 weight loss data — 12 month update Page 3

Orforglipron Phase 2 weight loss data — 12 month update

JenPlateau Wed, Sep 11, 2024 at 8:13 PM 29 replies 2,118 viewsPage 3 of 6
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Sep 15, 2024 at 1:32 PM#11
NurseLeah_Nash said:
The gap between trial results and real-world results is consistent and it is not fraud.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

23 21EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 20 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Sep 15, 2024 at 4:27 PM#12
Dr.PainCLE said:
The manufacturing argument is the underrated one.

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

Last edited: Sep 15, 2024 at 7:27 PM
24 22LeilaHI, marcus_mpls, DeniseRN_TPA and 21 others
Reply Quote Save Share Report
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Sep 15, 2024 at 7:22 PM#13
NurseLeah_Nash said:
The gap between trial results and real-world results is consistent and it is not fraud.

Pushing back on NurseLeah_Nash here. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

25 23HPLC_Greg, LibrarianMeg, bri_stats and 22 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Sep 15, 2024 at 10:17 PM#14

The figures, for anyone assembling their own picture. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Worth separating that from the trial evidence, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

26 24james_edin, FranDenver, Dr.BariatricHTX and 23 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 16, 2024 at 1:12 AM#15

Moderator note: a couple of off-topic posts removed. Thread quality here is what the rules are for. Keep it up.

Last edited: Sep 16, 2024 at 3:12 AM
27 0PurityPaulOR, MaxMetOK, MounjBrad and 24 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register